These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27314911)

  • 1. Recollections from a Pioneer Who Provided the Foundation for the Success of Gene Therapy in Treating Severe Combined Immune Deficiencies.
    Wilson JM
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):53-6. PubMed ID: 27314911
    [No Abstract]   [Full Text] [Related]  

  • 2. A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow.
    Kohn D; Wilson JM
    Hum Gene Ther Clin Dev; 2015 Dec; 26(4):203-7. PubMed ID: 26684443
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolving Gene Therapy in Primary Immunodeficiency.
    Thrasher AJ; Williams DA
    Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20 years of gene therapy for SCID.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Nat Immunol; 2010 Jun; 11(6):457-60. PubMed ID: 20485269
    [No Abstract]   [Full Text] [Related]  

  • 5. EMA greenlights second gene therapy.
    Mullard A
    Nat Rev Drug Discov; 2016 May; 15(5):299. PubMed ID: 27139988
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy's out-of-body experience.
    Scott CT; DeFrancesco L
    Nat Biotechnol; 2016 Jun; 34(6):600-7. PubMed ID: 27281416
    [No Abstract]   [Full Text] [Related]  

  • 7. ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization.
    Ylä-Herttuala S
    Mol Ther; 2016 Jun; 24(6):1013-1014. PubMed ID: 27324442
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy fulfilling its promise.
    Kohn DB; Candotti F
    N Engl J Med; 2009 Jan; 360(5):518-21. PubMed ID: 19179320
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy for genetic diseases.
    Anderson WF
    Hum Gene Ther; 1994 Mar; 5(3):281-2. PubMed ID: 8018743
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem-cell treatment brings a historic week in gene therapy.
    Jenks S
    J Natl Cancer Inst; 1993 Jun; 85(12):944-6. PubMed ID: 8496979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gene therapy of primary immunodeficiencies. Present and future].
    Serrano F; Laín de Lera T; González MA; García MJ; Abad JL; Bernad A
    Sangre (Barc); 1999 Apr; 44(2):143-53. PubMed ID: 10382324
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of ADA gene expression and transduction efficiency in ADA/SCID patients undergoing gene therapy.
    Carlucci F; Tabucchi A; Aiuti A; Rosi F; Floccari F; Pagani R; Marinello E
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1245-8. PubMed ID: 15571238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steps toward gene therapy: 1. The initial trials.
    Blaese RM
    Hosp Pract (1995); 1995 Nov; 30(11):33-40. PubMed ID: 8557801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte gene therapy.
    Culver KW; Anderson WF; Blaese RM
    Hum Gene Ther; 1991; 2(2):107-9. PubMed ID: 1911929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency.
    Williams DA
    Mol Ther; 2009 Apr; 17(4):577-8. PubMed ID: 19337228
    [No Abstract]   [Full Text] [Related]  

  • 16. A Promising Option for ADA-SCID Patients.
    Am J Med Genet A; 2021 Nov; 185(11):3184-3185. PubMed ID: 34655170
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy for ADA-SCID, the first marketing approval of an
    Aiuti A; Roncarolo MG; Naldini L
    EMBO Mol Med; 2017 Jun; 9(6):737-740. PubMed ID: 28396566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe immunodeficiencies: bone marrow transplantation or gene therapy?
    Mariani SM
    MedGenMed; 2003 Jun; 5(2):19. PubMed ID: 14603118
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.
    Hoogerbrugge PM; Vossen JM; v Beusechem VW; Valerio D
    Hum Gene Ther; 1992 Oct; 3(5):553-8. PubMed ID: 1420454
    [No Abstract]   [Full Text] [Related]  

  • 20. Looking into a Crystal Ball: An Interview with Ron Crystal.
    Davies K
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):97-101. PubMed ID: 31535944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.